🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines
Updated 04 Jul 2026 · HPRA open data

BIAL-Portela & Ca, S.A. — Licensed Medicines

7 medicines held by BIAL-Portela & Ca, S.A. on the Irish market, from the HPRA register of authorised products.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9
← All medicines · 7 products held by BIAL-Portela & Ca, S.A.
MedicineActive substanceLicence holderStatus
Ongentys 25 mg hard capsules
EU/1/15/1066/001
Opicapone BIAL-Portela & Ca, S.A.
Ongentys 50 mg hard capsules
EU/1/15/1066/002-007
Opicapone BIAL-Portela & Ca, S.A.
Zebinix 200 mg Tablet
EU/1/09/514/021-023
Eslicarbazepine acetate BIAL-Portela & Ca, S.A.
Zebinix 400 mg Tablet
EU/1/09/514/1-6
Eslicarbazepine acetate BIAL-Portela & Ca, S.A.
Zebinix 50 mg/ml Oral suspension
EU/1/09/514/024
Eslicarbazepine acetate BIAL-Portela & Ca, S.A.
Zebinix 600 mg Tablet
EU/1/09/514/7-11
Eslicarbazepine acetate BIAL-Portela & Ca, S.A.
Zebinix 800 mg Tablet
EU/1/09/514/12-20
Eslicarbazepine acetate BIAL-Portela & Ca, S.A.
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 20 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (“Authorised or Transfer Pending Products”), licensed CC BY 4.0, refreshed daily. Regulatory information only — not medical advice.